Amarin Corporation PLC (AMRN) is a Healthcare · Drug Manufacturers - General company listed on NASDAQ. Price $13.63 (-1.73%), Market cap $0.29B, 52-week low–high $10.98 ~ $20.25.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in
Financial statements, price targets, institutional (13F) holdings and related news for Amarin Corporation PLC are updated in real time on BlackAll Trade.
Amarin Corporation PLC trades at $13.63 (-1.73%). Real-time quotes and charts are available on BlackAll Trade.
Amarin Corporation PLC has a market cap of about $0.29B.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and intern